BioVivo Science Showcases BrocoVio O And VeriPalmetto At Fi Europe 2026

Nov 17, 2026

Leave a message

Michael Brown
Michael Brown
Michael is an international sales representative of Shaanxi Medibridge Biotech. He is proficient in multiple languages and has a wide network in the global pharmaceutical, health and beauty, and scientific research industries. He is committed to promoting the company's products to the international market.
news-1536-1024

BrocoVio O Uses Organic U.S.-Grown Broccoli Seeds

BioVivo manufactures BrocoVio O at its certified organic facility in Jeffersonville, Indiana, using organic broccoli seeds grown in the United States. It is the first ingredient introduced under the company's BrocoVio broccoli extract platform. BioVivo selected the seeds for their naturally high glucoraphanin content. Glucoraphanin is a glucosinolate that can be converted into sulforaphane, giving formulators a specific constituent to track when evaluating the ingredient. BioVivo announced organic certification for both the ingredient and the Indiana facility in October and is presenting the extract in Frankfurt for organic dietary supplement formulations.

 

VeriPalmetto Offers Florida-Sourced Extracts in Liquid and Powder Formats

VeriPalmetto is made from the berries of saw palmetto (Serenoa repens) harvested in the wild in Florida. Trade publication Nutritional Outlook reported that BioVivo processes the berries at its Jeffersonville facility. The company offers the extract in liquid and fine-powder forms and lists fatty acid specifications of 15%, 25%, 45%, 85% and 95% across the range. The physical format and fatty acid concentration are separate formulation considerations. The format influences how an extract is incorporated, while the concentration determines how much ingredient is needed to reach a specified fatty acid content.

news-1536-1024

 

news-1536-1024

Authentication Combines Supply Chain Records and Analytical Testing

BioVivo says it uses high-performance thin-layer chromatography, isotope analysis and mass spectrometry to authenticate saw palmetto material and screen for potential adulteration. The supplier also reports checking fatty acid composition and residual solvents before release. These tests address different questions about the material, including whether its chemical profile is consistent with the declared botanical and whether it meets applicable release specifications. This distinction matters in the saw palmetto market because industry guidance has documented adulterant blends that can mimic aspects of authentic extracts' fatty acid profiles.

 

Indiana Facility Supports a Wider Botanical Portfolio

The two extracts are part of a broader display at booth 31G108, where BioVivo is also presenting Wisconsin-grown American ginseng, cranberry extracts, plant-derived caffeine, rosemary and stevia. Its Jeffersonville facility opened in 2025 following a reported $70 million investment. The 100,000-square-foot site brings extraction, purification, spray drying, granulation and blending together, with an initial annual capacity of more than 2,000 metric tons of powdered extracts across the facility. BioVivo is using the Frankfurt show to introduce European formulators to both its botanical portfolio and its contract processing capabilities.

news-1536-1024

 

 

Send Inquiry